Steinberg Leigh is identified as a new insider of FibroBiologics, Inc., where Leigh serves as a director. The designation matters to investors because it connects a named board member with the company’s reported insider-position record, while the regulatory record also identifies FibroBiologics under ticker FBLG.

Key Highlights

  • The regulatory record was submitted to the U.S. Securities and Exchange Commission.
  • The document identifies FibroBiologics, Inc. under ticker FBLG.
  • The submission is designated as Form 3, covering a new insider position.

New Insider Position Recorded The

regulatory record was submitted to the U.S. Securities and Exchange Commission. It is designated as Form 3 and concerns a new insider position involving Steinberg Leigh. FibroBiologics, Inc (NASDAQ: FBLG). is identified in the record by ticker FBLG. Steinberg Leigh is described as a director of the company.